EverestIMS Technologies IPO
BSE SME · 29 Sep–5 Oct 2026
Half market demand (GMP, subscription, institutional bids), half offer-document data (valuation, profit trend, fresh issue vs OFS, debt, promoters, sector). Missing inputs are left out, not guessed. Not an apply/avoid recommendation.
3 archived readings. Marketframe stores its own observations; readings before we began archiving cannot be backfilled.
3 archived readings. Marketframe stores its own observations; readings before we began archiving cannot be backfilled.
49.41% unofficial premium
98.91× subscribed
Not published yet
Not in the RHP notes yet
Not in the RHP notes yet
Offer split unavailable
Not in the RHP notes yet
Not in the RHP notes yet
Sector not set yet
What is the GMP of EverestIMS Technologies today?
The latest unofficial grey market premium for EverestIMS Technologies is ₹42 (49.41% of the upper price band), sourced from InvestorGain. GMP is unofficial and unregulated.
What is the price band of EverestIMS Technologies?
The price band is ₹85 per share, as reported by InvestorGain for this BSE SME issue.
When does EverestIMS Technologies open and close?
The issue window is 29 Sep–5 Oct 2026. The current status is open.
How much is EverestIMS Technologies subscribed?
EverestIMS Technologies is subscribed 98.91× across all categories, per InvestorGain.
Is EverestIMS Technologies a good IPO to apply for?
Marketframe does not publish apply or avoid calls. The Marketframe score combines market demand (GMP, subscription, institutional bids) with facts from the offer document (valuation against listed peers, profit trend, fresh issue vs OFS, debt, promoter holding and sector record). It is an automated summary of data, not a recommendation or investment advice. Read the RHP and consult a SEBI-registered adviser.
↑Price band published
↑Fully subscribed at 98.91×
!Schedule, price and subscription are from InvestorGain, not checked against BSE
!GMP is unofficial and not verified by NSE
!Read the RHP risk factors before applying
Schedule, price band and live subscription data are sourced from InvestorGain for this BSE SME issue, not directly from BSE. *GMP is sourced from InvestorGain, is unofficial and unregulated. The Marketframe score summarises market demand and offer-document data; it does not predict listing gains or returns. Marketframe does not provide investment advice. Verify every decision using SEBI, NSE, BSE and the relevant offer document.